Does MOGAMULIZUMAB Cause Insomnia? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Insomnia have been filed in association with MOGAMULIZUMAB (POTELIGEO). This represents 4.8% of all adverse event reports for MOGAMULIZUMAB.
21
Reports of Insomnia with MOGAMULIZUMAB
4.8%
of all MOGAMULIZUMAB reports
14
Deaths
10
Hospitalizations
How Dangerous Is Insomnia From MOGAMULIZUMAB?
Of the 21 reports, 14 (66.7%) resulted in death, 10 (47.6%) required hospitalization, and 5 (23.8%) were considered life-threatening.
Is Insomnia Listed in the Official Label?
Yes, Insomnia is listed as a known adverse reaction in the official FDA drug label for MOGAMULIZUMAB.
What Other Side Effects Does MOGAMULIZUMAB Cause?
Rash (59)
Disease progression (46)
Infusion related reaction (42)
Pyrexia (35)
Febrile neutropenia (29)
Erythema (28)
Pruritus (26)
Drug ineffective (24)
Constipation (22)
Death (21)
What Other Drugs Cause Insomnia?
ADALIMUMAB (6,888)
DULOXETINE (5,270)
ETANERCEPT (4,983)
PREGABALIN (4,882)
METHOTREXATE (4,757)
LEVOTHYROXINE (4,663)
TOCILIZUMAB (4,001)
PREDNISONE (3,804)
LENALIDOMIDE (3,651)
RITUXIMAB (3,637)
Which MOGAMULIZUMAB Alternatives Have Lower Insomnia Risk?
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC
MOGAMULIZUMAB vs MOLNUPIRAVIR
MOGAMULIZUMAB vs MOLSIDOMINE
MOGAMULIZUMAB vs MOMELOTINIB
MOGAMULIZUMAB vs MOMETASONE